State Street’s Windtree Therapeutics Inc WINT Stock Holding History

State Street’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,670	Closed	-$11K	–	3751
2015 Q4	$11K	Hold	3,670	–	–	﹤0.01%	3692
2015 Q3	$15K	Hold	3,670	–	–	﹤0.01%	3678
2015 Q2	$35K	Hold	3,670	–	–	﹤0.01%	3622
2015 Q1	$61K	Hold	3,670	–	–	﹤0.01%	3569
2014 Q4	$60K	Sell	3,670 -422	-10%	-$9.28K	﹤0.01%	3573
2014 Q3	$104K	Hold	4,092	–	–	﹤0.01%	3516
2014 Q2	$102K	Hold	4,092	–	–	﹤0.01%	3470
2014 Q1	$123K	Hold	4,092	–	–	﹤0.01%	3493
2013 Q4	$129K	Buy	4,092 +2,443	+148%	+$76.4K	﹤0.01%	3471
2013 Q3	$45K	Sell	1,649 -257	-13%	-$6.23K	﹤0.01%	3535
2013 Q2	$40K	Buy	+1,906	New	+$47K	﹤0.01%	3466

Other funds holding WINT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street's WINT Position: Q1 2016 in Review

State Street sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 3,670 shares — an estimated $11K sold.

State Street first reported a position in WINT in Q2 2013 and held it in 11 quarters. The position peaked at $129K in Q4 2013. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

State Street reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
State Street sold 3,670 Windtree Therapeutics Inc shares in Q1 2016, an estimated $11K.
State Street first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 11 quarters.
State Street's Windtree Therapeutics Inc position peaked at $129K in Q4 2013.
34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on State Street's 13F filing for Q1 2016, filed 12 May 2016.